Use of ribofuranose derivatives against inflammatory bowel diseases

作者: Victor Brantl

DOI:

关键词: MoietyChemistryPharmacologyStereochemistryInflammatory Bowel DiseasesAmidineCarboxamideInflammatory bowel disease

摘要: A method for the prophylaxis or treatment of an inflammatory bowel disease is provided, comprising administering to a patient having at risk developing therapeutically preventatively effective amount one more ribofuranose derivatives Formula (I): wherein R group selected from carboxamide, amidine, and pharmaceutically acceptable acid addition salts thereof, configuration C 2 carbon moiety D L. The (I) may be used in combination with further active agents such as antivirals against disease.

参考文章(12)
Kandasamy Ramasamy, Zhi Hong, Robert Tam, Johnson Lau, Nucleoside analogs with carboxamidine modified monocyclic base ,(2001)
Heather Hobbs, Suzanne Elaine Keeling, David George Allen, Brian Cox, Chuen Chan, Joanna Victoria Geden, Richard Peter Charles Cousins, Shiping Xie, Alison Judith Redgrave, Thomas Davis Roper, 2- (purin-9-yl) -tetrahydrofuran-3,4-diol derivatives ,(1999)
Robert C. Tam, Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes Official Gazette of the United States Patent and Trademark Office Patents. ,(1998)
Devron Averett, Kandasamy Ramasamy, Robert Tam, Monocyclic L-nucleosides, analogs and uses thereof ,(1997)
Robert Tam, Devron Averett, Kandasamy Ramasamy, Moncyclic L-nucleosides analogs ,(2000)
Arthur F Lewis, Kandasamy Ramasamy, Natarajan Raju, Roland K Robins, Ramesh Bharadwaj, Vjera Pejanovic, Procedures for obtaining ribo-c-nucleosides ,(1996)